T Bond
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Child Abuse and Trauma 1
- Journals
- The Lancet (6 papers)The Lancet Diabetes & Endocrinology (1 paper)The Lancet Infectious Diseases (1 paper)The Lancet Child & Adolescent Health (1 paper)Bristol Research (University of Bristol) (1 paper)
- Partner nations
- AustraliaUnited KingdomIndonesia
In The Last Decade
T Bond
9 papers receiving 1.6k citations
T Bond's Hit Papers
Peers
Comparison fields: 5 of 99
- Infectious Diseases 962
- Applied Microbiology and Biotechnology 50
- Neurology 344
- Internal Medicine 56
- Obstetrics and Gynecology 86
Countries citing papers authored by T Bond
This map shows the geographic impact of T Bond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Bond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Bond more than expected).
Fields of papers citing papers by T Bond
This network shows the impact of papers produced by T Bond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Bond. The network helps show where T Bond may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 5 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 6 | 2023 | 83 | |
| 7 | 2023 | 24 | |
| 8 | 2024 | 23 | |
| 9 | 2025 | 5 | |
| 10 | Prevention of child abuse | 1995 | 0 |
About T Bond
T Bond is a scholar working on Infectious Diseases, Clinical Psychology, Surgery, Sociology and Political Science and Insect Science, having authored 10 papers that have together received 1.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Child Abuse and Trauma (1 paper), Homicide, Infanticide, and Child Abuse (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (962 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (344 citations), Internal Medicine (56 citations) and Obstetrics and Gynecology (86 citations). T Bond has collaborated with scholars based in Australia, United Kingdom and Indonesia. Their work appears in journals such as The Lancet, The Lancet Diabetes & Endocrinology, The Lancet Infectious Diseases, The Lancet Child & Adolescent Health and Bristol Research (University of Bristol).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.